Vertex Pharmaceuticals (VRTX)

Add to Watchlists
Create an Alert
64.17 -0.22  -0.34% NASDAQ Apr 17, 8:00PM BATS Real time Currency in USD
View Full Chart
VRTX Price Chart
View All Events

VRTX Events

Date Type Description
May 01 Misc Q1 2014 Vertex Pharmaceuticals Inc Earnings Conference Call
May 01 Earnings Q1 2014 Vertex Pharmaceuticals Inc Earnings Results. Estimate: -0.79.
Jan 29 Misc Vertex Pharmaceuticals 4Q2013 Earning Conference Call
Jan 29 Earnings Vertex Pharmaceuticals 4Q2013 Earning Result. Estimate: -0.57.
Oct 29 Misc Q3 2013 Conference Call
Oct 29 Earnings Vertex to Announce Third Quarter 2013 Financial Results on October 29. Estimate: -0.37.
Jul 29 Misc Vertex to Announce Second Quarter 2013 Financial Results on July 29
Jul 29 Earnings Vertex to Announce Second Quarter 2013 Financial Results on July 29. Estimate: -0.19.
May 08 Misc AGM Event for Vertex Pharmaceuticals, Inc.
Apr 30 Misc Vertex Pharmaceuticals First Quarter Earnings Conference Call
View All Performance Charts

VRTX Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Vertex Pharmaceuticals is up 18.73% over the last year vs S&P 500 Total Return up 23.54%, Amgen up 7.42%, and Biogen Idec up 42.37%.

Get Quote for

PDF Report for VRTX

Download Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.

Download VRTX Pro Report PDF
Advertisement

Portfolio Strategies Featuring VRTX

Did Vertex Pharmaceuticals make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

VRTX Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Headquarters Country: United States
  • Headquarters State/Province: Massachusetts
  • Incorporation Country: United States
  • Incorporation State/Province: Massachusetts
  • Est. Current Fiscal Quarter End: June 30, 2014
  • Est. Current Fiscal Year End: December 31, 2014
  • Last Fiscal Quarter End: N/A
  • Last Fiscal Year End: N/A
  • NAICS: Pharmaceutical Preparation Manufacturing
  • NAICS Code: 325412
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Industry Code: 3254
  • NAICS Sector: Manufacturing
  • NAICS Sector Code: 32

Vertex Pharmaceuticals, Inc. is a biotechnology company focused on the discovery, development and commercialization of breakthrough drugs for a range of serious diseases, including human immunodeficiency virus infection, chronic hepatitis C virus infection, inflammatory and autoimmune disorders, cancer, pain and bacterial infection, independently and with collaborators. Vertex was founded in 1989 by Kevin Kinsella and Larry Bock of Avalon Ventures and Gary Aronson. It is headquartered in Cambridge, Massachusetts.

Recent Quotes

Symbol Price Chg Chg % Market Cap
VRTX 64.17 -0.22 -0.34% 15.00B
Create Watchlist from Quotes
Advertisement

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

required
required
required
required
required
Get Started Now
document.write('');

{{root.upsell.info.feature_headline}}.
Upgrade to {{root.upsell.info.tier_name}}. Start Your YCharts Membership. Start your {{root.upsell.info.tier_name}} Membership

{{root.upsell.info.feature_description}}

{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{root.upsell.info.tier_name}} Member? Sign in here.